✦ LIBER ✦

Below-replacement fertility: Determinants and prospects in South Asia

✍ Scribed by Bruce K. Caldwell; John C. Caldwell

Publisher: Springer Netherlands
Year: 2003
Tongue: English
Weight: 125 KB
Volume: 20
Category: Article
ISSN: 1443-2447
DOI: 10.1007/bf03031793

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Below-replacement fertility and prospect

Below-replacement fertility and prospects for labour force growth in Taiwan

✍ Tsay Ching-lung 📂 Article 📅 2003 🏛 Springer Netherlands 🌐 English ⚖ 139 KB

Below-replacement fertility in east and

Below-replacement fertility in east and southeast asia: Consequences and policy responses

✍ Bhakta B. Gubhaju; Yoshie Moriki-Durand 📂 Article 📅 2003 🏛 Springer Netherlands 🌐 English ⚖ 138 KB

Below-replacement fertility in Thailand

Below-replacement fertility in Thailand and its policy implications

✍ Vipan Prachuabmoh; Preeya Mithranon 📂 Article 📅 2003 🏛 Springer Netherlands 🌐 English ⚖ 128 KB

Vocational education in south Asia: Prob

Vocational education in south Asia: Problems and prospects

✍ Jandhyala B. G. Tilak 📂 Article 📅 1988 🏛 Springer Netherlands 🌐 English ⚖ 732 KB

The occurrence of obtuse junction angles

The occurrence of obtuse junction angles and changes in channel width below tributaries along the Mekong River, south-east Asia

✍ Christopher Hackney; Paul Carling 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

A prospective cohort study determining t

A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase : Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study

✍ Lesley G. Mitchell;; the PARKAA Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 1 views

## Abstract ## BACKGROUND Thrombotic events (TEs) are serious secondary complications in children with acute lymphoblastic leukemia (ALL) who receive L‐asparaginase (ASP) therapy; however, the prevalence of TEs has not been established. The primary objective of the Prophylactic Antithrombin Replac